Xiaoyang Li Selected Research

Xiaoyang Li Research Topics

Disease

62	Neoplasms (Cancer) 04/2024 - 11/2012
13	Infections 01/2024 - 01/2016
11	Neoplasm Metastasis (Metastasis) 04/2024 - 11/2014
8	Inflammation (Inflammations) 04/2024 - 01/2020
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 01/2017
5	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 09/2017
5	Osteosarcoma (Osteogenic Sarcoma) 12/2021 - 07/2016
5	Carcinogenesis 01/2019 - 06/2014
4	Hypertension (High Blood Pressure) 04/2024 - 01/2023
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 02/2020
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2023 - 06/2012
4	Hematologic Neoplasms (Hematological Malignancy) 08/2023 - 01/2017
4	Hypoxia (Hypoxemia) 01/2022 - 03/2017
3	Fibrosis (Cirrhosis) 04/2024 - 01/2022
3	Melanoma (Melanoma, Malignant) 04/2024 - 01/2022
3	Adenocarcinoma of Lung 01/2024 - 01/2021
3	Leukemia 01/2024 - 07/2017
3	Cognitive Dysfunction 01/2024 - 01/2023
3	Wounds and Injuries (Trauma) 01/2024 - 01/2022
3	Lymphoma (Lymphomas) 12/2023 - 06/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2022
3	Poisoning 01/2023 - 01/2020
3	Synovial Sarcoma (Synovioma) 05/2022 - 01/2018
2	Rectal Neoplasms (Rectal Cancer) 04/2024 - 01/2015
2	Ulcerative Colitis 02/2024 - 11/2023
2	Colitis 12/2023 - 01/2023
2	Multiple Myeloma 08/2023 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 10/2020
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2022
2	Acute Promyelocytic Leukemia 12/2022 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 07/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2014
2	Hyperplasia 10/2021 - 08/2019
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2016
2	Necrosis 01/2020 - 01/2020
2	Demyelinating Diseases (Demyelinating Disease) 11/2019 - 11/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2018 - 09/2017
2	Liver Neoplasms (Liver Cancer) 01/2018 - 11/2016

Drug/Important Bio-Agent (IBA)

16	Histone Deacetylase InhibitorsIBA 01/2024 - 06/2014
12	Histone Deacetylases (Histone Deacetylase)IBA 12/2023 - 10/2014
11	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2016
5	InflammasomesIBA 03/2024 - 01/2021
5	ubenimexIBA 08/2023 - 01/2016
5	Fluorouracil (Carac)FDA LinkGeneric 11/2022 - 01/2016
4	LigandsIBA 04/2024 - 11/2018
4	VaccinesIBA 01/2024 - 01/2021
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2019
4	EnzymesIBA 01/2018 - 06/2014
3	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2018
3	AntibodiesIBA 01/2024 - 11/2017
3	Tyrosine Kinase InhibitorsIBA 11/2023 - 01/2021
3	Chimeric Antigen ReceptorsIBA 08/2023 - 08/2018
3	ProdrugsIBA 01/2023 - 10/2016
3	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2017
3	Therapeutic UsesIBA 01/2023 - 12/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2017
3	GoldIBA 05/2019 - 01/2016
2	Peptides (Polypeptides)IBA 04/2024 - 11/2022
2	PotassiumIBA 04/2024 - 09/2021
2	CytokinesIBA 03/2024 - 01/2023
2	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 10/2022
2	Decitabine FDA Link 12/2023 - 08/2019
2	ErbB Receptors (EGF Receptor)IBA 11/2023 - 11/2014
2	Lenalidomide (CC 5013)FDA Link 08/2023 - 03/2016
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2023 - 01/2023
2	Memantine (Namenda)FDA Link 01/2023 - 01/2023
2	CarbohydratesIBA 01/2023 - 01/2022
2	Bone Cements (Bone Glue)IBA 01/2023 - 07/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 12/2021
2	Gemcitabine FDA Link 01/2023 - 11/2016
2	CalciumIBA 09/2022 - 01/2022
2	RNA Polymerase II (RNA Polymerase B)IBA 05/2022 - 01/2022
2	Cytotoxins (Cytolysins)IBA 05/2022 - 01/2016
2	PanobinostatIBA 01/2022 - 06/2014
2	AntigensIBA 01/2022 - 10/2021
2	Messenger RNA (mRNA)IBA 12/2021 - 10/2021
2	NanovaccinesIBA 10/2021 - 01/2021
2	ApigeninIBA 01/2021 - 08/2019
2	ChromatinIBA 01/2020 - 01/2017
2	Histones (Histone)IBA 01/2020 - 01/2017
2	Vorinostat FDA Link 01/2018 - 05/2015
2	Capecitabine (Xeloda)FDA Link 01/2018 - 10/2016

Therapy/Procedure

30	Therapeutics 04/2024 - 06/2014
12	Drug Therapy (Chemotherapy) 02/2024 - 06/2012
7	Radiotherapy 04/2024 - 01/2021
7	Immunotherapy 01/2024 - 08/2018
4	Neoadjuvant Therapy 05/2024 - 01/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2023 - 08/2018
2	Precision Medicine 01/2022 - 12/2018
2	Oral Administration 01/2022 - 11/2016
2	Transplantation 01/2022 - 01/2016